Clinical Enrollment

As a company founded by an IRD patient, this announcement is near and dear to our hearts. Core to our mission is serving patients and meeting them where they are - both figuratively and literally. This partnership with Sano Genetics and 20/20 Onsite will provide the concierge service that patients deserve as they consider clinical trials as part of their care journey. And for all of the sponsors we work with - we are collaboratively able to identify and screen the most qualified patients possible in a seamless (and cost effective!) flow.

Here at CE we think about the work that we do and the stakeholders that we serve a little differently than most. In fact, we think it's the reason we're so successful! https://lnkd.in/ebpYF64a

We're #hiring a new Clinical Trial Site Relationship Manager in Charlottesville, Virginia. Apply today or share this post with your network.

Attending CRO Summit next month in Raleigh (or live/work in the area)? Join us for some cocktails and conversation on December 2nd. We're excited to be co-hosting next month's Triangle Bio Connections event with our good friends TSTrials and Block Clinical Inc. RSVP Below. https://lnkd.in/eXBR95_C

20/20 Onsite is proud to partner with Sano Genetics and Clinical Enrollment to advance care and clinical research for patients with inherited retinal diseases (IRDs). This collaboration simplifies access to genetic testing, personalized support, and clinical trials. 20/20 Onsite will provide onsite patient screenings through Mobile Vision Clinics. Sano Genetics will offer genetic testing, counseling, and a virtual patient education platform. Clinical Enrollment will manage patient recruitment, medical record retrieval, and logistics. Combining our strengths reduces barriers to care, especially for underserved communities, and accelerates clinical research timelines to bring vision-saving treatments to more patients. Learn how this partnership is expanding patient access to specialized care and research: https://hubs.ly/Q02VFd100 #ClinicalResearch #Ophthalmology #InheritedRetinalDisease #GeneticTesting #PatientCare

This past Friday, we announced a joint partnership with 20/20 Onsite and Clinical Enrollment to help solve for many of the challenges in finding the right participants for Inherited Retinal Disease (IRD) trials. You can read more about the partnership here: https://lnkd.in/e9m5yFsh I am beyond grateful to be working with incredible colleagues, including Sonali Bloom, Jessica McKenzie Mays, Katie Sigg, COT, OSA, OSC, Bryan Manning, and Jeff Eggeling on this collaboration. Never have I encountered a group of people who are so committed to doing the hard work of figuring out how to integrate multiple systems and business models in a short period of time to make things just a little easier for individuals and families that are looking for treatment options. If you are interested in learning more, please reach out! We would love to talk to you about what we are doing.

What am I most thrilled about at #AAO2024? If you are in Chicago, I would be thrilled to say hello.

Attending American Academy of Ophthalmology conference in Chicago this week? Want to have a cocktail and hear about the most exciting partnership in IRD Clinical Research? Join Clinical Enrollment 20/20 Onsite and Sano Genetics this Friday. Space is limited, contact Jeff Eggeling [email protected] about attending. Can't make it but want to learn more? Send us a message!

The #NobelPrize in #Chemistry was just announced, and it will change drug development forever. Using?#AI,?we can now model what a protein structure will look like, meaning we can test structures that do not appear in nature to help us find treatments, preventions and cures in the future in months rather than years.